FACA Committee Purpose & Justification The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML Part 1, Strategic Plan, format. Fiscal Year:2011 Committee Type: Other NCI Frederick Advisory Committee HHS 0a1e033b-5563-44c7-aaa8-abced7fe8f88 [ Location : (http://stratml.fido.gov/dick/HHSFACA76836.xml) ][ Federated Name : (urn:www.hhs.gov:agency:32:committee:76836:) ][ Agency Name : (Department of Health and Human Services) ][ Agency Acronym : (HHS) ][ Agency Domain : (www.hhs.gov) ] [ Agency Web Site : (http://www.hhs.gov/) ][ Committee Name : (NCI Frederick Advisory Committee) ][ Committee Type : (Other) ][ Committee Web Site : (http://deainfo.nci.nih.gov/advisory/fac/fac.htm) ][ Goal? : (yes) ][ Vision? : (yes) ][ Mission? : (yes) ] Department of Health and Human Services http://www.hhs.gov/ http://deainfo.nci.nih.gov/advisory/fac/fac.htm The Committee will consist of 16 members, including the Chair, appointed by the Director, NCI. Members will be authorities knowledgeable in drug and vaccine development, clinical trials support, AIDS research, bioinformatics, genomics, nanotechnology, biological repositories, and basic research in immunology and infectious diseases. Additionally, a nonvoting representative from the National Cancer Advisory Board, the NCI Board of Scientific Advisors, and the NCI Board of Scientific Counselors (Basic Sciences and Clinical Sciences and Epidemiology) will serve for the duration of their terms on their respective Boards. Ex officio members include the NCI Deputy Directors select NCI Division Directors and the Associate Director, NCI-Frederick. The Committee will review major new projects proposed to be performed at NCI-Frederick and advise the Director, NCI and Associate Director, NCI-Frederick about the intrinsic merit of the projects and about whether they should be done at the Frederick facility. In addition, this Committee will periodically review the existing portfolio of projects at NCI-Frederick, evaluate their productivity, help determine which of these projects should be transitioned to more conventional mechanisms of support, i.e., (grants, contracts, cooperative agreements) and which should be considered for termination. The Committee will help to assure that the operations at NCI-Frederick are open, transparent, and in the best interests of the entire cancer research community. The Committee will submit a written description of the research and its recommendations to the Director, NCI, Deputy Directors, NCI, and the Associate Director, NCI-Frederick. The Chair will submit a written description of the results annually to the National Cancer Advisory Board. 78d4c946-cfc5-4b4f-b238-3d1061ea24f8 The goal of NIH research is to acquire new knowledge to help prevent, detect, diagnose, and treat disease and disability, from the rarest genetic disorder to the common cold. The NIH mission is to uncover new knowledge that will lead to better health for everyone. NIH works toward that mission by the National Cancer Institute- Frederick Advisory Committee (NFAC). The Committee will review major new projects proposed to be performed at NCI-Frederick and advise the Director, NCI and Associate Director, NCI-Frederick about the intrinsic merit of the projects and about whether they should be done at the Frederick facility. In addition, this Committee will periodically review the existing portfolio of projects at NCI-Frederick, evaluate their productivity, help determine which of these projects should be transitioned to more conventional mechanisms of support, i.e., (grants, contracts, cooperative agreements) and which should be considered for termination. The Committee will help to assure that the operations at NCI-Frederick are open, transparent, and in the best interests of the entire cancer research community. The Committee will submit a written description of the research and its recommendations to the Director, NCI, Deputy Directors, NCI, and the Associate Director, NCI-Frederick. The Committee Chair will submit a written description of the results annually to the National Cancer Advisory Board. e03f8581-f210-404a-9dfb-f65a80c555e3 This Committee is composed of recognized biomedical research authorities from outside the NIH in order to secure unbiased and objective evaluation of research performed at NCI-Frederick. Their recommendations are invaluable because the complex nature of the research requires a unique balance and breadth of expertise not available at NIH or from other established sources. e3102b97-0297-4551-bb9c-b9919bee5c3b 43e72a74-837d-4f4e-adc4-ee1d15ceea64 42e274b8-285d-4f13-b684-423a77380273 2010-10-01 2011-09-30 2013-07-09 http://explore.data.gov/resource/datasets/c5i3-bb9j Gannon (J.) Dick gannon_dick@yahoo.com